Le Lézard
Classified in: Health
Subject: AWD

The Relief Productstm Wins 2019 DSN Retail Excellence Award - Natural


RENO, Nev., Jan. 17, 2019 /PRNewswire/ -- The Relief Productstm, a leading innovator in creating homeopathic remedies for chronic and acute conditions, has been honored with the prestigious DSN Retail Excellence (REX) award in the Natural category. 

The Relief Productstm

As the trusted voice of the retail pharmacy marketplace, Drug Store News (DSN) is the number one source of news, knowledge, and networking in the industry.  DSN evaluates hundreds of HBC Brands in the Natural space, awarding only a handful of manufacturers who have made a significant difference in the Natural Category over the past several years.

Selected for being an industry disruptor for over 30 years, The Relief Productstm offers a wide-range of homeopathic remedies in Eye & Ear Care, Cold & Cough Remedies, Digestive Health, and Pain Management.  "We are proud to offer products that are made using 100% natural active ingredients that work safely and gently with your body, offering no known side effects or interactions with other medications.  It is such an honor to receive the REX award from DSN and to be recognized for our continued growth and innovation among all the successful HBC brands that are on the market today," says Susan Hanson, COO.

As a family owned and operated company, The Relief Productstm is dedicated to its mission of helping as many people as possible Stay Healthy, Naturally®. This calling is fulfilled by offering over 25 uniquely formulated products that align with the consumer's desire to have safe and effective alternatives for common ailments in the modern world.  For example, Eye Strain Relieftm is designed to relieve eye strain symptoms caused by extended screen time on digital devices. Whereas, Stye Relief® is a homeopathic ointment for the temporary relief of stye symptoms such as itching, burning, tearing, and swollen bumps on the eyelid.  Furthermore, mothers choose Pink Eye Relief® for their children as a safe alternative to treat symptoms such as redness, burning, watering, and crusting in the eyes. Finally, Ring Relief® Ear Drops provide temporary relief from the symptoms of tinnitus ? an ailment that, according to the American Tinnitus Association, approximately 50 Million Americans suffer from every year.  Looking ahead to 2019, the company's newly introduced line of PM Ointments provides natural remedies for conditions whose symptoms typically worsen at night, such as pink eye, tinnitus, earaches, blepharitis and allergies.  For the complete line of homeopathic remedies, please visit thereliefproducts.com.

Full Article:
http://www.nxtbook.com/nxtbooks/ensembleiq/dsn_201901/index.php#/48

Media Contact:
[email protected] 
(203)880-4579
thereliefproducts.com

SOURCE The Relief Products


These press releases may also interest you

at 16:15
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
DexCom, Inc. today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an...



News published on and distributed by: